AI System Development for Genomics and Bioinformatics
Genomics generates data faster than analysis methods can keep up. One whole-genome variant analysis (WGS) produces 100–300 GB per sample. With thousands of samples in a cohort, you are looking at petabytes of data. We work with all data types: short reads (Illumina), long reads (PacBio, ONT), single-cell, methylome, and proteomic profiles. Our AI systems turn this flood into diagnostic and research insights. We bring 10+ projects in bioinformatics, guaranteeing reproducibility and full-cycle implementation. To give a concrete cost example, a WGS variant calling pipeline for 1000 samples typically costs around $120,000, reducing analysis time from 24 hours to 45 minutes per genome and saving $200,000 annually in computational expenses for a clinical lab.
Why AI Is Necessary for Genomics Analysis
Traditional pipelines (GATK, SAMtools) struggle with scale: the human genome has 3 billion base pairs, 4–5 million variants per sample. AI methods (deep learning) handle noise, detect complex structural variations, and predict functional effects with accuracy beyond heuristics. Clinical genomics already leverages AI for rare disease diagnosis and oncology.
Core Bioinformatics Tasks with AI
Variant Calling
Detection of SNVs, indels, CNVs, and SVs from NGS. DeepVariant on pileup images outperforms GATK: precision-recall AUC +3.2 percentage points on difficult regions. GPU acceleration (NVIDIA Clara Parabricks) reduces WGS analysis time from 24 hours to 45 minutes.
Variant Annotation
Out of 4 million SNVs per genome, we isolate pathogenic ones (<10 for a rare disease). Tools: CADD score for integrated pathogenicity scoring; AlphaMissense (DeepMind) predicts missense effects for 72% of all possible variants; SpliceAI for splicing impact.
Functional Genomics
Enformer (Transformer from DeepMind) predicts gene expression profiles from DNA sequence using ENCODE data, allowing interpretation of non-coding variants.
Transcriptomics
- Differential expression: DESeq2, edgeR with AI-based batch correction.
- Single-cell RNA-seq: scVI, SCGEN — variational autoencoders for normalization and integration.
- Cell type annotation: automatic annotation against reference atlases.
Proteomics
AlphaFold2 — 200M+ predicted structures, open access. ESM-2 (Meta) — protein language model for embeddings. Protein-protein interaction prediction.
Microbiome
Taxonomic classification of 16S rRNA, machine learning on OTU tables for disease associations.
| AI Model | Application | Advantage |
|---|---|---|
| DeepVariant | Variant calling | More accurate than GATK on hard regions |
| AlphaMissense | Missense variant annotation | Covers 72% of variants |
| Enformer | Regulatory genomics | Predicts expression from sequence |
| scVI | scRNA-seq | Batch correction and integration |
| AlphaFold2 | Protein structure | 200M+ predicted structures |
How We Deploy AI in Production
Pipelines and Infrastructure: We use Snakemake/Nextflow + Docker/Singularity for reproducibility. For enterprise, we use Cromwell (Broad Institute) + WDL. Cloud backends: AWS Batch, Google Life Sciences, Azure Batch. Data stored in CRAM (30-40% smaller than BAM) and object storage. For fast access, we use BGZF + tabix. HAIL for Spark-based distributed computing.
GPU Acceleration: NVIDIA Clara Parabricks runs full WGS analysis in 45 minutes instead of 24 hours on CPU. This is critical for clinical applications like neonatal genetics.
Clinical Applications:
- Rare diseases: WGS + AI prioritization with HPO phenotype yields a 25-35% diagnostic rate in previously undiagnosed patients.
- Oncogenomics: Tumor+normal analysis: somatic mutations, TMB, MSI, structural variants, neoantigens.
- Pharmacogenomics: CYP2D6 genotyping → CDS integration with dose adjustment. Reduces adverse drug reactions, saving up to 40% of related costs.
Case Study: For a rare disease cohort of 500 undiagnosed patients, we implemented a WGS pipeline with DeepVariant on NVIDIA Clara Parabricks, reducing analysis time from 24 hours to 45 minutes per genome. Combined with phenotype-based AI prioritization (HPO), we increased diagnostic yield from 15% to 32%.
| Task | Tools | Speed/Accuracy |
|---|---|---|
| Variant calling (WGS) | DeepVariant + Parabricks | 50-80x faster than CPU |
| Variant annotation | CADD, AlphaMissense, SpliceAI | AUC +3% vs GATK |
| scRNA-seq analysis | scVI, SCGEN | Batch correction, integration |
| Protein structure | AlphaFold2, ESM-2 | 200M structures |
Process of Work
- Analytics — Data audit, problem definition (variant interpretation, expression, etc.).
- Design — Model selection, pipeline architecture.
- Implementation — Development, fine-tuning, testing on reference datasets.
- Testing — A/B testing against classic pipelines, validation on GIAB/ClinVar.
- Deployment — Containerization, CI/CD, monitoring, MLOps (MLflow, Weights & Biases).
What's Included?
- Documentation: model cards, pipeline specifications.
- Access: to storage and GPU cluster.
- Team training on system use.
- Support: 3 months of operations, SLA for incidents.
Typical Mistakes in AI Implementation for Bioinformatics
- Ignoring batch effects in RNA-seq data.
- Missing validation checks for variant quality (GATK best practices).
- Insufficient sample size for fine-tuning: rule of thumb "1000+ samples for variant calling".
- Neglecting reproducibility: pipelines without containerization.
“Manual analysis of one exome takes a week, while an AI pipeline completes it in 3 hours” — client feedback from a rare disease lab.
Timeline: 4–8 months for a specific task; 2–3 months for infrastructure. Cost is determined individually. We evaluate your project within 2 days. Contact us for an engineer consultation.